Published in J Thorac Cardiovasc Surg on February 01, 2013
Reply to the editor. J Thorac Cardiovasc Surg (2013) 0.75
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg (2005) 2.80
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol (2013) 2.41
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol (2010) 2.24
The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J (2012) 1.88
Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. Am Heart J (2010) 1.87
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg (2011) 1.77
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol (2013) 1.76
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv (2011) 1.71
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg (2013) 1.55
Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg (2005) 1.54
Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg (2005) 1.54
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Circ Cardiovasc Qual Outcomes (2012) 1.50
Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention (2008) 1.47
The European Association for Cardio-Thoracic Surgery (EACTS) database: an introduction. Eur J Cardiothorac Surg (2013) 1.42
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv (2013) 1.42
Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann Thorac Surg (2008) 1.41
Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J (2012) 1.29
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22
Preoperative and operative predictors of delirium after cardiac surgery in elderly patients. Eur J Cardiothorac Surg (2012) 1.22
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol (2013) 1.11
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J (2006) 1.10
2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention (2015) 1.08
EACTS guidelines for the use of patient safety checklists. Eur J Cardiothorac Surg (2012) 1.07
Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg (2011) 1.07
A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg (2013) 1.06
Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung. Eur J Cardiothorac Surg (2003) 1.05
Current concepts on coronary revascularization in diabetic patients. Eur Heart J (2011) 1.05
Guideline for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg (2013) 1.03
Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg (2006) 0.98
Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg (2011) 0.98
Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag (2011) 0.97
Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects. Eur Heart J (2013) 0.96
Predicting prognosis in cardiac surgery: a prophecy? Eur J Cardiothorac Surg (2012) 0.96
What the cardiothoracic surgeon wants to know from the radiologist: from X-ray reporting to imaging consultancy and Heart Team membership. Pediatr Radiol (2015) 0.95
Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg (2003) 0.95
The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J (2013) 0.94
Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention (2013) 0.94
Non-inferiority study design: lessons to be learned from cardiovascular trials. Eur Heart J (2012) 0.93
Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters. Ann Thorac Surg (2005) 0.93
Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J (2012) 0.93
The SYNTAX score and its clinical implications. Heart (2013) 0.92
Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur J Cardiothorac Surg (2007) 0.91
Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg (2013) 0.87
The 4th European Association for Cardio-Thoracic Surgery adult cardiac surgery database report. Interact Cardiovasc Thorac Surg (2011) 0.86
Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg (2009) 0.86
Long-term follow-up and quality of life after closure of ventricular septal defect in adults. Eur J Cardiothorac Surg (2007) 0.86
Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. Eur Heart J (2013) 0.85
The role of EuroSCORE II in 21st century cardiac surgery practice. Eur J Cardiothorac Surg (2012) 0.84
The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention (2012) 0.83
[2014 ESC/EACTS Guidelines on myocardial revascularization]. Kardiol Pol (2014) 0.83
A crucial factor in shared decision making: the team approach. Lancet (2011) 0.81
Cost effectiveness of coronary revascularisation. EuroIntervention (2010) 0.81
Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg (2012) 0.81
Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv (2012) 0.81
Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress? Semin Thorac Cardiovasc Surg (2012) 0.81
Usefulness of microsimulation to translate valve performance into patient outcome: patient prognosis after aortic valve replacement with the Carpentier-Edwards supra-annular valve. J Thorac Cardiovasc Surg (2007) 0.80
Patient selection for transcatheter aortic valve replacement: what does the future hold? Expert Rev Cardiovasc Ther (2012) 0.79
Transcatheter aortic valve implantation after PARTNER: what is up next? EuroIntervention (2010) 0.79
How to assess risks of valve surgery: quality, implementation and future of risk models. Heart (2009) 0.79
Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery. JAMA (2013) 0.77
Complexity of coronary vasculature predicts outcome of surgery for left main disease. Ann Thorac Surg (2009) 0.77
Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery. Curr Opin Pharmacol (2012) 0.76
Surgical implications of coronary arterial anatomy in adults with congenital cardiac disease. Open Cardiovasc Med J (2008) 0.75
Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med (2012) 0.75
Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation. J Am Coll Cardiol (2011) 0.75
Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel. JAMA (2011) 0.75
Methodologic issues regarding background mortality in observational studies. J Thorac Cardiovasc Surg (2011) 0.75
Surgical or transcatheter mitral valve intervention: complex disease requires complex decisions. EuroIntervention (2014) 0.75
Long-term survival of young patients with coronary artery disease is best realized through surgical revascularization with mammary arteries. J Am Coll Cardiol (2013) 0.75
Details in a meta-analysis comparing mitral valve repair to replacement for ischemic regurgitation. Eur J Cardiothorac Surg (2012) 0.75
Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation. Interact Cardiovasc Thorac Surg (2013) 0.75
Virtual reality 3D echocardiography in the assessment of tricuspid valve function after surgical closure of ventricular septal defect. Cardiovasc Ultrasound (2007) 0.75
Invited commentary. Ann Thorac Surg (2012) 0.75
A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team. EuroIntervention (2017) 0.75
Outcome after aortic valve replacement in young adults: is patient profile more important than prosthesis type? J Heart Valve Dis (2006) 0.75
Failing surgical bioprosthesis in aortic and mitral position. EuroIntervention (2013) 0.75
Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice. Expert Rev Cardiovasc Ther (2013) 0.75
The bright future of cardiothoracic and vascular surgery: the role of EACTS. Eur J Cardiothorac Surg (2013) 0.75
Management of elderly patients with aortic valve disease. Nat Clin Pract Cardiovasc Med (2008) 0.75
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies. EuroIntervention (2016) 0.75
Emergency surgery due to haematoma in a case of left atrial myxoma. Heart Lung Circ (2006) 0.75
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS). EuroIntervention (2011) 0.75
Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial. EuroIntervention (2017) 0.75